MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-02-0008865
Glarizonto Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.42 Cr
▼ 3% YoY
Net profit · FY 2025
₹5.37 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹22.62 Lakh
EBITDA margin 6.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
About Glarizonto Pharma Private Limited
Data last updated:
Glarizonto Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2017PTC120347. Its GSTIN is 36AAHCG0590P1Z4 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Latha Padinharu Veettil and Raghu Peediyekal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.42 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹5.37 Lakh (net margin 1.6%) and EBITDA of ₹22.62 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹30 Lakh on record.
Glarizonto Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0008865). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glarizontopharma.com.
Company details
CIN U24299TG2017PTC120347
Registration Number 120347
Incorporation Date 31 October 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0008865
Recognitions & Rankings of Glarizonto Pharma
Contact details
Glarizonto Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is glarizontopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No 37 – 33 First Floor Middle Portion, Swarnashar Defence Colony, Hyderabad, Telangana, India – 500094
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Glarizonto Pharma Private Limited, buy the company report.
Comprehensive company report
Glarizonto Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Glarizonto Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glarizonto Pharma Private Limited, buy the company report.
Financials of Glarizonto Pharma Private Limited
FY 2025 filings availableGlarizonto Pharma Private Limited reported revenue of ₹3.42 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹3.42 Cr ▼ 3%
Net profit · FY 2025
₹5.37 Lakh margin 1.6%
EBITDA · FY 2025
₹22.62 Lakh margin 6.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 7%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 73%
5 years · compounded
▲ 41%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glarizonto Pharma Private Limited, buy the company report.
Board of directors of Glarizonto Pharma Private Limited
Glarizonto Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Latha Padinharu Veettil | Director | 31 Oct 2017 | 9 Years 0 Months | Current |
| Raghu Peediyekal | Director | 31 Oct 2017 | 9 Years 0 Months | Current |
| Rajesh Parakkel | Director | 23 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Glarizonto Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lifeshield Formulations Private Limited | ₹3.42 Cr (FY 2025) | 5.0% | Agra, Uttar Pradesh, India | |||
| Puizer Pharmaceutical (OPC) Private Limited | ₹3.42 Cr (FY 2025) | 157.0% | Jhunjhunu, Rajasthan, India | |||
| Welspun Tradewel Limited | ₹3.42 Cr (FY 2018) | 404.0% | Vapi, Gujarat, India | |||
| Hoe Exim Private Limited | ₹3.42 Cr (FY 2016) | 51.0% | Mumbai, Maharashtra, India | |||
| Bacda International Private Limited | ₹3.42 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India | |||
| Glarizonto Pharma Private Limitedthis company | ₹3.42 Cr (FY 2025) | ₹5.37 Lakh | 1.6% | -3.0% | Hyderabad, Telangana, India | |
| Devyog Commercial Limited | ₹3.42 Cr (FY 2024) | -53.0% | Kolkata, West Bengal, India | |||
| Shree Salasar Balaji Teak Forest Private Limited | ₹3.42 Cr (FY 2017) | -44.0% | Tal Anjar, Gujarat, India | |||
| Ma-Mansa Fisheries Private Limited | ₹3.42 Cr (FY 2024) | 50.0% | Hooghly, West Bengal, India | |||
| Hridhaan Wellness Private Limited | ₹3.42 Cr (FY 2025) | 50.0% | Pune, Maharashtra, India | |||
| Geo Express Private Limited | ₹3.42 Cr (FY 2016) | 1.0% | Delhi, India |
To see the full peer comparison of Glarizonto Pharma Private Limited, buy the company report.
Auditor
Glarizonto Pharma Private Limited is audited by MANKALA AND CHIKKALA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANKALA AND CHIKKALA | FY 2023 | 016019S |
Shareholding
The shareholding of Glarizonto Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Glarizonto Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Nov 2020 | 100419323 | Others | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Glarizonto Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glarizonto Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glarizonto Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCG0590P1Z4 | Telangana | Active | 28 Feb 2018 |
To see the full GST registrations and return filing status of Glarizonto Pharma Private Limited, buy the company report.
Recent activity
Glarizonto Pharma Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Rajesh Parakkel was appointed as Director on 23 Jul 2018.
AGM
Glarizonto Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Glarizonto Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100419323 was registered on 06 Nov 2020.
Appointed
Rajesh Parakkel was appointed as Director.
Appointed
Latha Padinharu Veettil was appointed as Director.
Appointed
Raghu Peediyekal was appointed as Director.
Incorporation
31 Oct 2017
Glarizonto Pharma Private Limited was registered on 31 Oct 2017 with Roc Hyderabad & aged 9 years 2 days as per MCA records.
Frequently asked questions
Glarizonto Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 October 2017 (9+ years old) and is registered under CIN U24299TG2017PTC120347.
Glarizonto Pharma has 3 current directors:
- Latha Padinharu Veettil - Director
- Raghu Peediyekal - Director
- Rajesh Parakkel - Director
The latest financial statements of Glarizonto Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Glarizonto Pharma is 36AAHCG0590P1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Glarizonto Pharma is U24299TG2017PTC120347. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glarizonto Pharma was incorporated on 31 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Glarizonto Pharma by revenue are Lifeshield Formulations Private Limited, Puizer Pharmaceutical (OPC) Private Limited, Welspun Tradewel Limited, Hoe Exim Private Limited, Bacda International Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rajesh Parakkel was appointed as Director on 23 Jul 2018. Latha Padinharu Veettil was appointed as Director on 31 Oct 2017. Raghu Peediyekal was appointed as Director on 31 Oct 2017.
Yes, Glarizonto Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0008865).
Glarizonto Pharma can be reached through the website glarizontopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Glarizonto Pharma is at H.No 37 – 33 First Floor Middle Portion, Swarnashar Defence Colony, Hyderabad, Telangana, India – 500094.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages